Literature DB >> 2462676

Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes.

T A Potter1, T V Rajan, R F Dick, J A Bluestone.   

Abstract

The CD8 (Lyt 2) molecule is a phenotypic marker for T lymphocytes that recognize and react with major histocompatibility complex (MHC) class I molecules. Antibody blocking experiments and gene transfection studies indicate that CD8 binds to a determinant on MHC class I molecules on the target cells, facilitating interaction between effector T lymphocytes and the target cell. The CD8 molecule may also be involved in transmembrane signalling during T-cell activation. The existence of CD8- cytotoxic T lymphocytes (CTL) and class I-reactive CTL that are not inhibited by antibody to CD8 suggests that at least some CTL do not require the CD8 molecule to interact with and lyse target cells. We have recently demonstrated that cells transfected with an H-2Dd gene that carries a mutation at residue 227 are not killed by primary CTL8. Here we show that although this mutation abrogates recognition by primary CTL, it does not affect recognition by CD8-independent CTL, suggesting that residue 227 of class I molecules might contribute to a determinant that is the ligand of the CD8 molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462676     DOI: 10.1038/337073a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

3.  Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection.

Authors:  Kristie M Grebe; Raedun L Clarke; Terry A Potter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

4.  Identification of a shark sequence resembling the major histocompatibility complex class I alpha 3 domain.

Authors:  K Hashimoto; T Nakanishi; Y Kurosawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule.

Authors:  J M Connolly; T H Hansen; A L Ingold; T A Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse.

Authors:  Pia P Yachi; Jeanette Ampudia; Nicholas R J Gascoigne; Tomasz Zal
Journal:  Nat Immunol       Date:  2005-06-26       Impact factor: 25.606

7.  Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.

Authors:  T A Potter; K Grebe; B Freiberg; A Kupfer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  A mutation in the alpha 3 domain of Db that abrogates CD8 binding does not affect presentation of an immunodominant H-Y peptide.

Authors:  J P Dutz; S J Teh; N Killeen; H S Teh
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

Review 9.  Co-receptors and recognition of self at the immunological synapse.

Authors:  Nicholas R J Gascoigne; Tomasz Zal; Pia P Yachi; John A H Hoerter
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

10.  A new function for LAT and CD8 during CD8-mediated apoptosis that is independent of TCR signal transduction.

Authors:  Raedun L Clarke; Sandra Thiemann; Yosef Refaeli; Guy Werlen; Terry A Potter
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.